NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 149 filers reported holding NEOGENOMICS INC in Q2 2018. The put-call ratio across all filers is 1.36 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $249,000 | -34.3% | 30,510 | -2.2% | 0.00% | 0.0% |
Q1 2022 | $379,000 | -62.4% | 31,210 | +5.8% | 0.00% | -66.7% |
Q4 2021 | $1,007,000 | -31.1% | 29,510 | -2.6% | 0.01% | -30.8% |
Q3 2021 | $1,462,000 | +6.4% | 30,310 | -0.3% | 0.01% | +8.3% |
Q2 2021 | $1,374,000 | +1.0% | 30,410 | +7.8% | 0.01% | 0.0% |
Q1 2021 | $1,361,000 | -38.7% | 28,210 | -31.6% | 0.01% | -42.9% |
Q4 2020 | $2,221,000 | +27.1% | 41,250 | -12.9% | 0.02% | +10.5% |
Q3 2020 | $1,747,000 | -3.4% | 47,350 | -18.9% | 0.02% | -9.5% |
Q2 2020 | $1,808,000 | -11.7% | 58,350 | -21.4% | 0.02% | -12.5% |
Q1 2020 | $2,048,000 | -29.1% | 74,190 | -24.9% | 0.02% | +4.3% |
Q4 2019 | $2,888,000 | +41.9% | 98,736 | -7.2% | 0.02% | +35.3% |
Q3 2019 | $2,035,000 | -29.6% | 106,436 | -19.2% | 0.02% | -22.7% |
Q2 2019 | $2,890,000 | -1.5% | 131,735 | -8.2% | 0.02% | 0.0% |
Q1 2019 | $2,935,000 | +53.9% | 143,435 | -5.2% | 0.02% | +37.5% |
Q4 2018 | $1,907,000 | -34.8% | 151,235 | -20.6% | 0.02% | -20.0% |
Q3 2018 | $2,924,000 | +14.1% | 190,519 | -2.6% | 0.02% | +17.6% |
Q2 2018 | $2,563,000 | -8.3% | 195,519 | -42.9% | 0.02% | -10.5% |
Q1 2018 | $2,794,000 | +189.5% | 342,379 | +214.4% | 0.02% | +216.7% |
Q4 2017 | $965,000 | +47.1% | 108,900 | +84.9% | 0.01% | +50.0% |
Q3 2017 | $656,000 | -26.5% | 58,900 | -40.9% | 0.00% | -33.3% |
Q2 2017 | $893,000 | +46.9% | 99,700 | +29.5% | 0.01% | +50.0% |
Q1 2017 | $608,000 | +5.9% | 77,000 | +14.9% | 0.00% | 0.0% |
Q4 2016 | $574,000 | +39.7% | 67,000 | +34.0% | 0.00% | +33.3% |
Q3 2016 | $411,000 | +2.2% | 50,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $402,000 | -33.8% | 50,000 | -44.4% | 0.00% | -25.0% |
Q1 2016 | $607,000 | -3.7% | 90,000 | +12.5% | 0.00% | 0.0% |
Q4 2015 | $630,000 | -15.4% | 80,000 | -38.5% | 0.00% | -20.0% |
Q3 2015 | $745,000 | -8.3% | 130,000 | -13.3% | 0.01% | +25.0% |
Q2 2015 | $812,000 | +15.8% | 150,000 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $701,000 | +68.1% | 150,000 | +50.0% | 0.00% | +100.0% |
Q4 2014 | $417,000 | -37.2% | 100,000 | -50.0% | 0.00% | -33.3% |
Q2 2014 | $664,000 | – | 200,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |